Xsensio's wearable chip that analyses proteins and hormones in real time draws €6 million | EU-Startups
Xsensio, a Lausanne-based DeepTech company developing near real-time continuous biochemical monitoring, announced the successful closing of a €6 million ($7 million) oversubscribed Series A financi...

Source: EU-Startups
Xsensio, a Lausanne-based DeepTech company developing near real-time continuous biochemical monitoring, announced the successful closing of a €6 million ($7 million) oversubscribed Series A financing round. The round was led by VC firm WI Harper, with participation from Privilège Ventures, the European Innovation Council, and private investors across the United States, Europe, and Asia. “This […]